Mishkin GE, Kohn EC. Biomarker development: bedside to bench.
Clin Cancer Res 2022;
28:2722-2724. [PMID:
35481871 DOI:
10.1158/1078-0432.ccr-22-0750]
[Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/17/2022] [Revised: 04/18/2022] [Accepted: 04/22/2022] [Indexed: 11/16/2022]
Abstract
This commentary complements the report from Nixon and colleagues by addressing the critical definitions, assay and analytical quality control and interpretation, and resources available to advance similar fit-for-purpose biomarker development.
Collapse